The strong, independent association of IL-32 with inferior survival in patients, the reduced proliferative rate, and the reduction of OXPHOS in three phenotypically different cell lines when depleting IL-32 strongly suggest that IL-32 plays a role in MM disease progression. This evidence concerns the gene IL32 and Miyoshi myopathy.